Xconomy National

Archives

by in

Entry	Author	Date	Location
Affymax Prepares to Mount Challenge to Amgen Anemia Drug Monopoly	Luke Timmerman	01/25/12	San Francisco
Acceleron Adds $30M From Partner Celgene and Existing Investors	Arlene Weintraub	12/23/11	Boston
Affymax Passes FDA Panel Scrutiny, Looks to Challenge Amgen Anemia Drug	Luke Timmerman	12/07/11	San Francisco
Affymax Shares Climb As FDA Considers Wider Use for Anemia Drug	Luke Timmerman	12/05/11	San Francisco
Affymax Gears Up for its Make-or-Break Moment, As Anemia Drug Faces FDA Scrutiny	Luke Timmerman	11/17/11	San Francisco
Acceleron, Celgene Take Aim at Amgen’s Multibillion-Dollar Anemia Market	Luke Timmerman	08/05/11	Boston
Acceleron Gets $25 Million in Partnership Deal With Celgene	Arlene Weintraub	08/03/11	Boston
FDA Says It Will Review Affymax Drug	Luke Timmerman	07/27/11	San Francisco
Affymax Raises $50M	Luke Timmerman	03/18/11	San Francisco
E-Commerce Pioneer Sets Up Cancer Commons, Affymax Hires New Boss, Plexxikon Opts In, & More Bay Area Life Sciences News	Luke Timmerman	01/07/11	San Francisco
Affymax Hires New CEO, Former Genentecher, to Complete FDA Push With Anemia Drug	Luke Timmerman	01/06/11	San Francisco
Alnylam Lays Out 2015 Goals	Luke Timmerman	01/06/11	Boston
Acceleron Pharma Cuts 40 Percent of Workforce	Luke Timmerman	11/03/10	Boston
Taligen Collects $10M For Focus on Rare Diseases	Ryan McBride	08/23/10	Boston
$8M for Acceleron	Erin Kutz	06/22/10	Boston
Affymax Tanks on Anemia Results	Luke Timmerman	06/21/10	San Francisco
SS&C Prices IPO, Amag Gets $60M from Takeda, Selecta Nabs $15M, & More Boston-Area Deals News	Erin Kutz	04/07/10	Boston
Avila Gets Leukemia & Lymphoma Society Funding, Dicerna Unites with Ipsen, Rhythmia to Test Heart Mapping Technology, Amag Licenses to Takeda, & More Boston-Area Life Sciences News	Erin Kutz	04/02/10	Boston
Amag Pharma Gets $60M Upfront in Licensing Deal with Takeda	Ryan McBride	04/01/10	Boston
Former Idera Pharma CEO at Helm of AesRx, New Startup With Sickle Cell Drug	Ryan McBride	01/05/10	Boston
Acceleron Pharma Reports $10.9M Financing	Ryan McBride	12/16/09	Boston
Acceleron Pharma Invests in Bricks & Mortar When Virtual is In Vogue	Luke Timmerman	12/10/09	Boston
Amgen’s Seattle and Boston Teams Seek to Boost Biotech Hit Rate 20 to 30 Percent	Luke Timmerman	10/09/09	National
Acceleron, Bucking Conventional Wisdom, Pushes Ahead Drug For Bone Loss, Anemia	Luke Timmerman	09/11/09	Boston
Acadia Takes a Fall, CareFusion Spins Off, Life Technologies Takes $450M in Cash, & More San Diego Life Sciences News	Bruce V. Bigelow	09/03/09	San Diego
San Diego’s Palkion Chases Amgen’s Big Market, Joins Race to Develop Oral Anemia Drug	Luke Timmerman	09/01/09	San Diego
San Diego Biotech Startups Raise New Cash to Treat Anemia, Heart Disease and More	Bruce V. Bigelow	08/19/09	San Diego
Amag Pharmaceuticals Wins FDA Approval to Sell Iron Deficiency Drug	Luke Timmerman	06/30/09	Boston
GlycoFi Figures Heavily into Drug Giant Merck’s Follow-on Biologics Plans	Ryan McBride	04/23/09	Boston
Amgen Cuts 100 Jobs in Bothell	Luke Timmerman	04/09/09	Seattle
Page 1 of 2	next page »